Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP)

CUSIP: 45339J105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
113,265,306
Total 13F shares
500,710
Share change
-1,211,484
Total reported value
$1,306,000
Price per share
$2.61
Number of holders
12
Value change
-$3,185,888
Number of buys
4
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 45339J105?
CUSIP 45339J105 identifies INDP - Indaptus Therapeutics Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) as of Q2 2022

As of 30 Jun 2022, Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 500,710 shares. The largest 10 holders included VANGUARD GROUP INC, INVESTMENT HOUSE LLC, GEODE CAPITAL MANAGEMENT, LLC, Stratos Wealth Partners, LTD., Vivaldi Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, NORTHERN TRUST CORP, Harel Insurance Investments & Financial Services Ltd., and Tower Research Capital LLC (TRC). This page lists 12 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.